Clinical Trial

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 30, 2024 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective multicenter clinical study. This study aims to construct an auxiliary decision-making system for lung cancer immunotherapy combined with radiotherapy by fusing three modes of imagomics, clinicopathological features, and molecular pathological features.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-10-17; most recent amendment 2024-05-28.
Status change: Not Yet Recruiting → Recruiting 2023-12-25
Trial Details
NCT Number NCT05584267
Lead Sponsor Hunan Province Tumor Hospital
Conditions Non Small Cell Lung Cancer
Enrollment 140 participants
Start Date 2022-12-25
Primary Completion 2025-11-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-30